Gene · 4900
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study. | Alzheimers Dement | 2023 | 36648169 | PubTator, text mining | PubMed |
| Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells? | J Adv Res | 2023 | 36646419 | PubTator, text mining | PubMed |
| Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study. | Alzheimers Res Ther | 2023 | 36631909 | PubTator, text mining | PubMed |
| The recency ratio assessed by story recall is associated with cerebrospinal fluid levels of neurodegeneration biomarkers. | Cortex | 2023 | 36630749 | PubTator, text mining | PubMed |
| Evaluation of Coronary Flow Level with Mots-C in Patients with STEMI Undergoing Primary PCI. | Arq Bras Cardiol | 2023 | 36629605 | PubTator, text mining | PubMed |
| How does IL-6 change after combined treatment in MDD patients? A systematic review. | Brain Behav Immun Health | 2023 | 36624849 | PubTator, text mining | PubMed |
| Ensemble feature selection with data-driven thresholding for Alzheimer's disease biomarker discovery. | BMC Bioinformatics | 2023 | 36624372 | PubTator, text mining | PubMed |
| Neurogranin in Alzheimer's disease and ageing: A human post-mortem study. | Neurobiol Dis | 2023 | 36623608 | PubTator, text mining | PubMed |
| Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study. | J Alzheimers Dis | 2023 | 36617786 | PubTator, text mining | PubMed |
| Astroglial toxicity promotes synaptic degeneration in the thalamocortical circuit in frontotemporal dementia with GRN mutations. | J Clin Invest | 2023 | 36602862 | PubTator, text mining | PubMed |
| Biomarkers of Activity-Dependent Plasticity and Persistent Enhancement of Synaptic Transmission in Alzheimer Disease: A Review of the Current Status. | Med Sci Monit | 2023 | 36600577 | PubTator, text mining | PubMed |
| Deep multimodal predictome for studying mental disorders. | Hum Brain Mapp | 2023 | 36574598 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis. | Endocr Connect | 2023 | 36562664 | PubTator, text mining | PubMed |
| Recent advances in characterization of citrullination and its implication in human disease research: From method development to network integration. | Proteomics | 2023 | 36546832 | PubTator, text mining | PubMed |
| Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients. | Alzheimers Dement | 2023 | 36516028 | PubTator, text mining | PubMed |
| The genetic regulation of protein expression in cerebrospinal fluid. | EMBO Mol Med | 2023 | 36504281 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders. | Mov Disord | 2023 | 36504237 | PubTator, text mining | PubMed |
| The diagnostic and prognostic value of serum neurogranin in acute ischemic stroke. | J Stroke Cerebrovasc Dis | 2023 | 36481578 | PubTator, text mining | PubMed |
| Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances. | Curr Neuropharmacol | 2023 | 36475335 | PubTator, text mining | PubMed |
| Role of non‑coding RNAs as biomarkers and the application of omics technologies in Alzheimer's disease (Review). | Int J Mol Med | 2023 | 36453246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4900/papers?page=20